Drugs / MB-002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00087984 | Jan 2004 → Sep 2008 | renal cell carcinoma | Argos Therapeutics | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MB-002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00087984 ↗ |